会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Imidazole-substituted quinoxalinedione derivatives
    • 咪唑取代的喹喔啉二酮衍生物
    • US6121264A
    • 2000-09-19
    • US194750
    • 1998-12-02
    • Shuichi SakamotoJunya OhmoriJun-ichi ShishikuraMasamichi OkadaMasao Sasamata
    • Shuichi SakamotoJunya OhmoriJun-ichi ShishikuraMasamichi OkadaMasao Sasamata
    • C07D403/04A61K31/495C07D521/00A61K31/498C07D403/10C07D403/14
    • C07D231/12C07D233/56C07D249/08
    • Imidazole-substituted quinoxalinedione derivatives represented by the following general formula (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions useful as glutamate receptor antagonists and the like, which comprise said compounds or salts thereof and pharmaceutically acceptable carriers. ##STR1## (Each symbol in the formula has the following meaning: A: a group represented by a formula (CH.sub.2).sub.m or a group represented by a formula Ph--(CH.sub.2).sub.p (Ph: a phenyl group),X: an oxygen atom or a group represented by a formula NR.sup.4,R.sup.1 : a hydrogen atom, a hydroxyl group or a triazolyl group, with the proviso that X may be a bond when R.sup.1 is a triazolyl group,R.sup.2 : a hydrogen atom, a nitro group, a halogeno-lower alkyl group, a cyano group, an amino group, a mono- or di-lower alkylamino group or a halogen atom,R.sup.3 and R.sup.4 : may be the same or different from each other and each represents a hydrogen atom or a lower alkyl group,n: 0, 1 or 2,m: an integer of 2 to 6, andp: an integer of 1 to 6.
    • PCT No.PCT / JP97 / 01905 Sec。 371日期1998年12月2日第 102(e)日期1998年12月2日PCT提交1997年6月5日PCT公布。 公开号WO97 / 46555 日期:1997年12月11日由以下通式(I)表示的咪唑取代的喹喔啉二酮衍生物或其药学上可接受的盐以及用作谷氨酸受体拮抗剂等的药物组合物,其包含所述化合物或其盐和药学上可接受的载体。 (式中的每个符号具有以下含义:A:由式(CH 2)m表示的基团或由式Ph-(CH 2)p(Ph:苯基)表示的基团,X:氧原子或 由式NR4表示的基团,R1:氢原子,羟基或三唑基,条件是当R 1为三唑基时,X可以为键,R 2为氢原子,硝基,卤代 低级烷基,氰基,氨基,一或二低级烷基氨基或卤素原子,R 3和R 4可以相同或不同,表示氢原子或低级烷基 基团,n:0,1或2,m为2〜6的整数,p为1〜6的整数。
    • 4. 发明授权
    • Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative
    • 红藻氨酸神经毒性抑制剂和吡啶并噻嗪衍生物
    • US6133258A
    • 2000-10-17
    • US68534
    • 1998-05-13
    • Jun-ichi ShishikuraHiroshi InamiTomoyuki YasunagaMasaaki HiranoShuichi SakamotoKazushige OhnoMasamichi OkadaShin-ichi Tsukamoto
    • Jun-ichi ShishikuraHiroshi InamiTomoyuki YasunagaMasaaki HiranoShuichi SakamotoKazushige OhnoMasamichi OkadaShin-ichi Tsukamoto
    • A61K31/5415A61K31/542C07D513/04
    • A61K31/5415
    • Neuroprotective agents based on inhibition of kainic acid neurotoxicity and compounds useful as neuroprotective agents based on inhibition of kainic acid neurotoxicity. An inhibitors of kainic acid neurotoxicity, comprising as an active ingredient a pyridothiazine derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof, and a pyridothiazine derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein symbols in the formula have the following respective meanings: the ring A: a pyridine ring; ##STR2## R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 may be the same or different and each represent a hydrogen atom or a lower alkyl, cycloalkyl, alkenyl, aryl, carboxyl or lower alkoxycarbonyl group which may have substituent(s), or are not present, with the proviso that R.sup.2 and R.sup.3 may together form a nitrogen-containing heterocyclic group which may have nitrogen atoms as another hetero atom, may be fused with a benzene ring and may have a lower alkyl group as a substituent.
    • PCT No.PCT / JP96 / 03339 Sec。 371日期1998年5月13日 102(e)日期1998年5月13日PCT 1996年11月14日PCT PCT。 出版物WO97 / 17970 日期1997年5月22日基于抑制红藻氨酸神经毒性的神经保护剂和基于抑制红藻氨酸神经毒性作用的神经保护剂的化合物。 作为活性成分的红藻氨酸神经毒性抑制剂,含有下述通式(I)所示的吡哆噻嗪衍生物或其药学上可接受的盐,以及下述通式(I)表示的吡哒嗪衍生物或其药学上可接受的盐 其中式中的符号具有以下各自的含义:环A:吡啶环; R 1,R 2,R 3,R 4和R 5可以相同或不同,各自表示氢原子或可以具有取代基或不存在的低级烷基,环烷基,烯基,芳基,羧基或低级烷氧基羰基, 条件是R2和R3可以一起形成可以具有氮原子作为另一个杂原子的含氮杂环基,可以与苯环稠合并且可以具有低级烷基作为取代基。
    • 6. 发明申请
    • IMAGE VIEWING GLASSES
    • 图像查看玻璃
    • US20120069294A1
    • 2012-03-22
    • US13231057
    • 2011-09-13
    • Hiroshi OhnoTatsuya SakataMasamichi OkadaNobuyuki HaraNaoto Shimizu
    • Hiroshi OhnoTatsuya SakataMasamichi OkadaNobuyuki HaraNaoto Shimizu
    • G02C5/22
    • G02B27/0176G02B2027/0178G02C5/2263G02C2200/18
    • A glasses-type shutter holder may include left and right temple parts connected respectively to left and right frame end parts of frame. The left and right temple parts may be foldable respectively with respect to the left and right frame end parts in accordance with movement, for each frame end part and temple part pair, of a contact position at which a movement part provided with one of the temple part and the frame end part of the pair is in contact with a contact part of the other of the temple part and the frame end part of the pair. For each of the pairs, the contact part is in contact with the movement part when the temple part is unfolded to a maximum degree, and a maximum degree of opening of the temple part is varied in accordance with the movement of the movable part.
    • 眼镜型快门保持器可以包括分别连接到框架的左框架和右框架端部的左右镜腿部分。 根据对于每个框架端部和镜腿部对的移动,左右镜腿部分可以分别相对于左框架和右框架端部折叠,该接触位置处设置有一个镜腿的移动部件 所述一对的所述框架端部与所述一对的所述镜腿部的另一方的接触部与所述一对的所述框的端部接触。 对于每一对,当镜腿部分展开最大程度时,接触部分与运动部分接触,并且根据可移动部件的移动来改变镜腿部分的最大开度。